BEAMing Microemulsion Beads for Genetic Variation Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing genetic variations are limited in accuracy and sensitivity, particularly when dealing with small numbers of DNA molecules that have subtle changes, as they struggle to count and quantify millions of molecules simultaneously without introducing instrumental and experimental noise.

Innovation Solution

The BEAMing method uses microemulsions with reagent beads bound to primers for amplifying DNA molecules, allowing for the formation of product beads with thousands of copies of a single DNA sequence, which are then separated and analyzed using flow cytometry, enabling the detection and quantification of genetic variations at a larger scale.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If digital techniques (single molecule PCR) are used to count DNA molecules, then measurement precision is improved, but productivity is worsened due to limited counting capacity of tens to thousands of molecules only

Engineering Contradiction:
Improveaccuracy of genetic variation detectionVSAvoidnumber of molecules that can be counted simultaneously
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention divides the DNA molecules into discrete beads, where each bead contains thousands of copies of a single DNA sequence. This segmentation allows parallel processing of millions of molecules while maintaining digital counting precision, as each bead acts as an independent unit that can be individually detected and counted by flow cytometry.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates amplified copies of DNA molecules on beads through PCR, where each bead contains thousands of copies of a single template sequence. This copying process enables the detection of rare variants by amplifying them to visible levels while maintaining the ability to count individual beads, thus achieving both high sensitivity and high throughput.

Inventive Principle:
Principle #26Copying

2Productivity

If analog techniques are used to assess millions of molecules simultaneously, then productivity is improved, but measurement precision is worsened due to instrumental and experimental noise

Engineering Contradiction:
Improvenumber of molecules that can be assessed simultaneouslyVSAvoidaccuracy of genetic variation detection
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

By segmenting DNA molecules onto discrete beads, the invention enables simultaneous assessment of millions of molecules through flow cytometry while maintaining precision. Each bead serves as an independent counting unit, allowing digital detection that avoids the noise problems of bulk analog measurement techniques.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention replaces bulk analog measurement with single-bead digital detection using flow cytometry. Instead of measuring signal intensity from millions of molecules simultaneously (analog approach), the system counts individual beads (digital approach), substituting mechanical/bulk measurement with optical/digital detection that provides higher precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If DNA molecules are amplified to increase detection sensitivity, then measurement precision is improved, but device complexity is worsened due to additional amplification steps and reagent requirements

Engineering Contradiction:
Improvesensitivity for detecting rare variantsVSAvoidcomplexity of amplification process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention merges the amplification process with the bead formation process. PCR amplification occurs directly on the beads during a single integrated step, combining template binding, amplification, and product generation into one operation. This eliminates the need for separate amplification steps and reduces reagent requirements compared to traditional multi-step protocols.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The beads themselves serve as the amplification platform, providing both the template binding surface and the amplification reaction environment. The bead-bound primers and nucleotides enable self-contained amplification on each bead, reducing the need for external reagents and simplifying the overall system design.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the accurate and sensitive analysis of genetic variations in millions of molecules, overcoming the limitations of existing digital and analog techniques by providing a reliable and automatable method for quantifying variant DNA molecules in a population.

Implementation Method 1

The analyte DNA molecules in the microemulsions are amplified in the presence of reagent beads which are bound to a plurality of molecules of a primer for amplifying the analyte DNA molecules

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 2

The product beads are separated from analyte DNA molecules which are not bound to product beads. A sequence feature of the single species of analyte DNA molecule that is bound to the product beads is determined

Methodology Applied
Scientific EffectFlow cytometry:

Implementation Method 3

The liquid composition comprises a plurality of microemulsions forming aqueous compartments

Methodology Applied
Scientific EffectMicroemulsion: Microemulsion

Data Source

PatentUS9328343B2Method and compositions for detection and enumeration of genetic variations
Publication Date: 2016.05.03 JOHNS HOPKINS UNIVERSITY
  • US9328343B2 patent drawing
  • US9328343B2 patent drawing
  • US9328343B2 patent drawing

AI summary

Many areas of biomedical research depend on the analysis of uncommon variations in individual genes or transcripts. Here we describe a method that can quantify such variation at a scale and ease heretofore unattainable. Each DNA molecule in a collection of such molecules is converted into a single particle to which thousands of copies of DNA identical in sequence to the original are bound. This population of beads then corresponds to a one-to-one representation of the starting DNA molecules. Variation within the original population of DNA molecules can then be simply assessed by counting fluorescently-labeled particles via flow cytometry. Millions of individual DNA molecules can be assessed in this fashion with standard laboratory equipment. Moreover, specific variants can be isolated by flow sorting and employed for further experimentation. This approach can be used for the identification and quantification of rare mutations as well as to study variations in gene sequences or transcripts in specific populations or tissues.